Pamela N. Münster

ORCID: 0000-0002-2074-0984

Also affiliated with University of San Francisco

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target”.

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Melanoma Research(2020)10.1097/cmr.0000000000000701

N/A

0.757DataRank · unranked

14 citations

Oliver Surriga, Daniel J. Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha +11 more

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

British Journal of Cancer(2023)10.1038/s41416-023-02298-8

N/A

0.681DataRank · unranked

11 citations

Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore +13 more

A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1076

N/A

0.449DataRank · unranked

19 citations

Amelia S. Gliwa, Siti Rahmaputri, H Dittrich, Melanie Majure, Hope S. Rugo +10 more

Preliminary efficacy data of triple-negative breast cancer cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1077

N/A

0.312DataRank · unranked

7 citations

Hatem Soliman, Siqing Fu, Karen A. Gelmon, Albiruni Ryan Abdul Razak, Pamela N. Münster +11 more

Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8563

N/A

0DataRank · unranked

0 citations

Marc R. Radke, Navid Hafez, Hatem Soliman, Siqing Fu, Shumei Kato +11 more

Late‐onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma

American Journal of Medical Genetics Part A(2022)10.1002/ajmg.a.62761

N/A

0DataRank · unranked

2 citations

Anne Slavotinek, Thomas N. Darling, Stanley Lipkowitz, Frederic G. Barr, Pamela N. Münster +3 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps8598

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Vinicius Ernani, Patrick M. Forde, Liza C. Villaruz +12 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8603

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Panos Savvides, Liza C. Villaruz, Patrick M. Forde +12 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464

N/A

0DataRank · unranked

0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464.v1

N/A

0DataRank · unranked

0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more

A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models.

Research Square(2023)10.21203/rs.3.rs-3459372/v1

N/A

0DataRank · unranked

0 citations

Elysia Roche, Pujan Desai, Nela Pawłowska, Diana Bauer, David Gingrich +5 more

Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors

Breast Cancer Research(2025)10.1186/s13058-024-01954-y

N/A

0DataRank · unranked

11 citations

Scott Thomas, Sibapriya Chaudhuri, Ann Lazar, Luika Timmerman, Pamela N. Münster +1 more

Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant

Scientific Reports(2025)10.1038/s41598-024-77186-z

N/A

0DataRank · unranked

1 citations

Elysia Roche, Pujan Desai, Nela Pawłowska, Diana Bauer, David Gingrich +5 more

Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9065

N/A

0DataRank · unranked

10 citations

Navid Hafez, Hatem Soliman, Siqing Fu, Shumei Kato, Primo N. Lara +12 more

Specialized computational methods for denoising, B1 correction, and kinetic modeling in hyperpolarized 13C MR EPSI studies of liver tumors

Magnetic Resonance in Medicine(2021)10.1002/mrm.28901

N/A

0DataRank · unranked

13 citations

Hsin‐Yu Chen, Jeremy W. Gordon, Zihan Zhu, Peder E. Z. Larson, Nicholas Dwork +11 more

Lisinopril or carvedilol in prevention of trastuzumab-induced cardiotoxicity in patients with HER2-positive early stage breast cancer: Longitudinal changes of left ventricular ejection fraction below normal levels (LVEF <50%).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.509

N/A

0DataRank · unranked

0 citations

Roy Tamura, Jeffrey P. Krischer, Worta J. McCaskill-Stevens, Maya Guglin, Pamela N. Münster